Maravai LifeSciences Holdings, Inc. Stock
Equities
MRVI
US56600D1072
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.34 USD | +0.18% | +7.69% | +73.13% |
Financials (USD)
Sales 2024 * | 275M | Sales 2025 * | 303M | Capitalization | 1.51B |
---|---|---|---|---|---|
Net income 2024 * | -32M | Net income 2025 * | -8M | EV / Sales 2024 * | 5.2 x |
Net cash position 2024 * | 73.18M | Net cash position 2025 * | 128M | EV / Sales 2025 * | 4.55 x |
P/E ratio 2024 * |
-52.1
x | P/E ratio 2025 * |
-107
x | Employees | 570 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 43.44% |
Latest transcript on Maravai LifeSciences Holdings, Inc.
1 day | +0.18% | ||
1 week | +7.69% | ||
Current month | +38.29% | ||
1 month | +55.34% | ||
3 months | +113.16% | ||
6 months | +130.02% | ||
Current year | +73.13% |
Managers | Title | Age | Since |
---|---|---|---|
William Martin
CEO | Chief Executive Officer | 49 | 22-09-29 |
Carl Hull
FOU | Founder | 66 | 14-02-28 |
Kevin Herde
DFI | Director of Finance/CFO | 53 | 17-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dean Mihas
BRD | Director/Board Member | 57 | 16-02-29 |
Sean Cunningham
BRD | Director/Board Member | 48 | 16-02-29 |
Gregory Lucier
BRD | Director/Board Member | 59 | 19-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.50% | 12 M€ | -.--% | - | |
0.37% | 8 M€ | +5.66% | ||
0.34% | 2 M€ | +10.27% | ||
0.28% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 11.34 | +0.18% | 1,947,740 |
24-05-17 | 11.32 | +1.98% | 1,655,169 |
24-05-16 | 11.1 | -0.89% | 1,680,547 |
24-05-15 | 11.2 | +4.67% | 1,616,871 |
24-05-14 | 10.7 | +1.61% | 1,897,010 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+73.13% | 1.51B | |
-31.06% | 9.41B | |
-8.43% | 3.03B | |
+27.31% | 2.9B | |
-14.31% | 2.16B | |
-18.94% | 1.7B | |
+30.25% | 814M | |
-1.97% | 760M | |
-26.73% | 529M | |
+5.17% | 312M |
- Stock Market
- Equities
- MRVI Stock